: In northwestern Kenya, Turkana County has been historically considered unsuitable for stable malaria transmission because of its unfavorable climate and predominantly semi-nomadic population; consequently, it is overlooked during malaria control planning. However, the area is changing, with substantial development, an upsurge in travel associated with resource extraction, and more populated settlements forming. Recently, numerous malaria outbreaks have highlighted the need to characterize malaria transmission and its associated risk factors in the region to inform control strategies. Reactive case detection of confirmed malaria cases at six health facilities across central Turkana was conducted from 2018 to 2019. Infections in household members of index cases were detected by malaria rapid diagnostic tests (RDTs) and PCR tests, and they were grouped according household and individual characteristics. The relationships between putative risk factors and infection were quantified by multilevel logistic regression models. Of the 3,189 household members analyzed, 33.6% had positive RDT results and/or PCR test results. RDT-detected infections were more prevalent in children; however, PCR-detected infections were similarly prevalent across age groups. Recent travel was rarely reported and not significantly associated with infection. Bed net coverage was low and net crowding was associated with increased risks of household infections. Infections were present year-round, and fluctuations in prevalence were not associated with rainfall. These findings indicate year-round, endemic transmission with moderate population immunity. This is in stark contrast to recent estimates in this area. Therefore, further investigations to design effective intervention approaches to address malaria in this rapidly changing region and other similar settings across the Horn of Africa are warranted.
Following the expansion of the World Health Organization’s guidelines on eligibility for the seasonal malaria chemoprevention (SMC), the government of Kenya prepared to implement SMC for a first time in Turkana Central Sub-County in 2024. To inform design of SMC, we conducted a baseline qualitative and quantitative study. Using a stratified cluster sampling approach, we enrolled 198 households with children 6 months - 5 years old, and tested all individuals one year and older using a Rapid Diagnostic Test (RDT) and polymerase chain reaction (PCR). We carried out 82 key informant interviews, 31 focus group discussions with community health workers, elders, and caretakers of children, and 60 In-depth interviews with caretakers. Malaria prevalence was 21% [9%-42%] as reported by RDT and 21% [11%-38%] by PCR. Prevalence varied across villages, with the highest positivity of 73% by PCR. While SMC was perceived positively, challenges identified included physical access (households far from village centers, pastoralists, children living in the streets); stigma (children living with disabilities, households with members struggling with alcohol use); and acceptability (traditionalists, highly educated households). This study found that while malaria burden is high in the region, SMC may be a feasible approach to reduce its burden and transmission. However, implementation of SMC should be tailored, with a combination of centralized distribution supplemented by door-to-door and outreach to pastoralists and people in the interior. Using existing grassroots structures, such as Tree of Men and religious and group leaders, and intensive mobilization will be critical for success of this intervention.
Background: Schistosomiasis remains a significant neglected tropical disease in Kenya, but its presence in the western/northern Lake Turkana region is poorly characterised. We conducted an exploratory serosurvey to assess evidence of Schistosoma spp. exposure and a diagnostic accuracy study to evaluate dried blood spots (DBSs) for field serology. Methods: We performed a cross-sectional survey in adults (≥18 years) from six communities in the western/northern and shoreline area of Turkana Lake, excluding individuals with >6 months of residence in other Kenyan endemic areas. Capillary blood was collected on DBSs and tested centrally using ELISA for Schistosoma spp. IgG. In parallel, DBS cards performance was compared with paired routine serum ELISA in 23 patients assessed for suspected schistosomiasis at our centre. Results: We enrolled 155 participants (60% men; median age 30 years), with nearly universal reported freshwater contact (154/155, 99.4%). In the validation study, DBS values were lower than serum values (mean bias 0.27), with moderate correlation (r = 0.54) and modest discrimination (AUC 0.65; sensitivity 80% and specificity 50% at OD index >0.8). The median DBS ELISA OD index for the 155 participants was 0.55 (IQR, 0.34–0.79). Six samples exceeded 0.8, but these values were low, and all had negative IHA (<1/80), yielding no confirmed seropositive cases. Conclusions: These findings suggest low or absent sustained transmission in the sampled communities during the study period and indicate that DBS-based serology is operationally feasible but requires careful calibration and confirmatory testing for robust field inference.